Order:
  1.  43
    One Advocate's Viewpoint: Conflicts and Tensions in the Baby K Case.Ellen J. Flannery - 1995 - Journal of Law, Medicine and Ethics 23 (1):7-12.
    What was really going on in the Baby K case? Many people have posed that or similar questions to me when I have been introduced as the attorney for Baby K's mother. In a nutshell, the courts in Baby K ruled that a hospital is required to provide emergency medical care to an anencephalic baby at the mother's request. In this paper, I provide some insights into the factors that underlie the litigation and the legal issues decided by the courts. (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  2.  14
    One Advocate's Viewpoint: Conflicts and Tensions in the Baby K Case.Ellen J. Flannery - 1995 - Journal of Law, Medicine and Ethics 23 (1):7-12.
    What was really going on in the Baby K case? Many people have posed that or similar questions to me when I have been introduced as the attorney for Baby K's mother. In a nutshell, the courts in Baby K ruled that a hospital is required to provide emergency medical care to an anencephalic baby at the mother's request. In this paper, I provide some insights into the factors that underlie the litigation and the legal issues decided by the courts. (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  3.  10
    Should It Be Easier or Harder to Use Unapproved Drugs and Devices?Ellen J. Flannery - 1986 - Hastings Center Report 16 (1):17-23.
    In applying statutory safeguards, the FDA must not regulate investigational new products so stringently that a life‐saving therapy is unavailable. But the agency must also protect dying patients from exploitation by unscrupulous or overzealous researchers. The balance between individual choice and public protection has been questioned in cases involving experimental AIDS drugs and an artificial heart.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark